sodium-dodecyl-sulfate and Calcinosis

Calcific band keratopathy (CBK) is a degenerative condition resulting in the deposition of calcium salts in the superficial layers of the cornea and causing significant visual disturbance and pain of the affected eye. Unfortunately, the amount of CBK precipitates recovered from the affected eye is very small therefore; it would be beneficial to prepare a synthetic material mimicking CBK material to further the development of therapeutics. Analyses of biological samples recovered from patients show the presence of silicon in addition to calcium, as well as a distinctive fused spherical morphology. This prompted us to study the reaction of various sources of silicon (fumed silica, silicic acid, and silicone oil) with CaCO(3) under a range of reaction conditions to gain an understanding of the formation of CBK. A silicon source alone was not found to be responsible for the fused spherical morphology, and a third component, a polar surfactant-like molecule such as sodium dodecyl sulfate or tetradecylphosphonic acid, was also required. The effects of silicon:calcium ratio and reaction time have been studied. The reaction of fumed silica with CaCO(3) in presence of sodium dodecyl sulfate results in the formation of spherical shapes resembling the structures and chemical composition observed in the eye samples, while no such structures were observed in the absence of silicon. Samples closely resembling human samples were also formed from the reaction of silicone oil with CaCO(3) in the presence of tetradecylphosphonic acid. Samples were characterized by SEM, XRD, and XPS and Raman spectroscopy.

Topics: Alkanes; Biocompatible Materials; Calcinosis; Calcium Carbonate; Corneal Diseases; Humans; Materials Testing; Molecular Structure; Organophosphonates; Phosphorous Acids; Silicic Acid; Silicon; Silicon Dioxide; Sodium Dodecyl Sulfate; Surface-Active Agents

We determined the possible effects of age, antimineralization treatments, circulatory implant conditions, prosthesis design, and valve-related structural aspects on valve calcification in adolescent sheep.. Calcium content was measured by means of atomic absorption spectrometry in bioprostheses implanted in 120 sheep (age <1 year) for a period of 3 or 6 months.. Bioprostheses calcified significantly in adolescent sheep, but the extent of calcification was multifactorial. Multivariate analysis of the calcium content reveals that age, mitral or pulmonary implant position, prosthesis design (stented or stentless), structure (porcine or pericardial, wall portion or cusp), and antimineralization treatment are independent factors influencing calcification; implant duration beyond 3 months was not. In juvenile sheep (age 5 months) the wall portion, as well as the cusps of the prosthesis, calcified significantly more than in adolescent sheep (age 11 months). Irrespective of age, the cusps of valves implanted in the mitral position calcified more than those in the pulmonary position. The wall portion of stentless valves calcified more than that of stented valves, and pericardial valves calcified less than porcine valves. The surfactant (Tween 80, No-React, and alpha-amino-oleic acid) and alcohol (ethanol and octanediol) treatment significantly reduced cusp calcification; sodium dodecylsulfate did not. None of the anticalcification treatments was able to prevent wall calcification in stentless porcine valves.. These findings suggest that tissue valve calcification is determined by many independent factors, which can be identified by using adolescent sheep as a preclinical in vivo model.

Topics: Age Factors; Animals; Aortic Valve; Bioprosthesis; Calcinosis; Calcium; Female; Heart Valve Prosthesis; Heart Valves; Multivariate Analysis; Oleic Acids; Polysorbates; Prosthesis Design; Pulmonary Valve; Sheep; Sodium Dodecyl Sulfate; Spectrophotometry, Atomic; Surface-Active Agents

The purpose of this study was to evaluate the effects of the calcification inhibitors FeCl3 and sodium dodecyl sulfate (SDS) on the morphology of glutaraldehyde-crosslinked type I collagen sponges and on their serum conditioning. Scanning electron microscopy (SEM) showed that the morphology of the sponges, already modified by glutaraldehyde crosslinking, underwent further changes after treatment of the hydrogels with inhibitors. Coral-like structures were found to branch from the bulk of the material especially in the case of SDS-treated samples. The composition and morphology of the conditioning layers was characterized after 48 h incubation in serum by SDS-polyacrylamide gel electrophoresis-immunoblot of the adsorbed proteins, by energy-dispersive X-ray analysis of the elements (EDX), and by SEM of the conditioned surfaces. All the samples showed the adsorption of proteins with molecular weights ranging from 10 to 203 kD. However, the peculiar adsorption of an approximately 10-kD band (complement C3 fragment) and of fibronectin were detected in the case of glutaraldehyde-crosslinked collagen. On the other hand, glutaraldehyde-crosslinked collagen treated with 0.1M FeCl3 showed the remarkable adsorption of a 29-kD band. The glutaraldehyde-crosslinked hydrogels showed the massive precipitation of crystals on their exposed surfaces, whereas a disordered network structure surrounding the collagen fibrils was found in the case of the samples pretreated with inhibitors. A predominant precipitation of sodium and chloride was detected in all the sponges, although the ratio between the peaks changed from from one hydrogel to another. The results reported in this article clearly indicate that the treatments with SDS and FeCl3 change the surface conditioning of collagen sponges, suggesting a possible role of deposited serum solutes in affecting mineralization processes on bioprosthesis.

Topics: Blood Physiological Phenomena; Calcinosis; Chlorides; Collagen; Cross-Linking Reagents; Culture Media, Conditioned; Electron Probe Microanalysis; Ferric Compounds; Glutaral; Heart Valve Prosthesis; Humans; Sodium Dodecyl Sulfate; Surgical Sponges

The in vitro calcification and enzymatic degradation of bovine pericardia (BP) after a series of surface treatments were studied as a function of exposure time. The degradation of these treated surfaces was monitored by scanning electron micrography and tensile strength measurements. Polyethylene glycol-(PEG) grafted BP and glutaraldehyde-(GA) treated BPs retained maximum stability in collagenase digestion compared with SDS-treated BP. The ability of alpha chymotrypsin, bromelain, esterase, trypsin, and collagenase to modulate the degradation of SDS-, GA-, PEG-, Carbodiimide-, and glycidylether-treated BPs also was investigated. Incubation of various enzymes to these crosslinked pericardia variably reduced the tensile strength of these tissues. It is conceivable that chemical treatments of pericardial tissues might have altered their physical and chemical configuration and the subsequent degradation properties. In vitro calcification studies showed a substantial reduction in the calcification profile of PEG-grafted bovine pericardia compared to other treated tissues. Furthermore, the biocompatibility aspects of pericardial tissues were established by platelet adhesion and octane contact angle. In conclusion, it seems that the surface modification of bovine pericardia via GA-PEG grafting may provide new ways of controlling biodegradation and calcification.

Topics: Animals; Biocompatible Materials; Biodegradation, Environmental; Blood Platelets; Calcinosis; Carbodiimides; Cattle; Collagenases; Cross-Linking Reagents; Endopeptidases; Epoxy Compounds; Esterases; Glutaral; Heart Valve Prosthesis; Microscopy, Electron, Scanning; Pericardium; Platelet Adhesiveness; Polyethylene Glycols; Sodium Dodecyl Sulfate; Surface Properties; Tensile Strength

Calcification of bioprosthetic heart valves fabricated from glutaraldehyde pretreated bovine pericardium or porcine aortic valves (PAV) is a frequent cause of the failure of these devices. Of all strategies considered thus far, only detergent preincubations using compounds such as sodium dodecyl sulfate (SDS) inhibited PAV bioprosthetic mineralization in circulatory sheep bioprosthetic valve replacements. The present study sought to characterize the mechanism of action of SDS preinicubation. Results of transport and material characterization studies showed that SDS had a relatively high affinity for PAV, with a maximum uptake of 167.1 +/- 6.8 micrograms SDS/mg tissue over 24 h at 37 degrees C with a partition coefficient of 19.3. The PAV diffusion of SDS was 1.95 +/- 0.35 10(-6) cm2/sec. The principal effect of SDS on PAV was phospholipid extraction. The residual organic phosphate in the SDS pretreated tissue was 2.22 +/- 0.72 nmol/mg tissue compared to the control untreated group with 18.52 +/- 2.1 nmol/mg tissue. Incubations of PAV specimens in a 1% SDS solution for 24 h significantly inhibited calcification after 21 days in subdermal implants in 3-week-old male rats (PAV Ca2+ = 18.0 +/- 11.8 micrograms/mg) compared to control (177.8 +/- 6.0 micrograms/mg). In contrast, coimplants of 30% SDS silicone rubber polymers, for regional sustained SDS administration, did not impede PAV calcification in 21 day implants Ca2+ = 166.0 +/- 14.0 micrograms/mg compared to the nondrug silicone matrix controls, Ca2+ = 173.0 +/- 6.6 micrograms/mg). Thus, we conclude that the mechanisms of SDS inhibition of PAV calcification is due to material effects which occur during preincubation, and is not facilitated by sustained SDS administration.

Topics: Animals; Aortic Valve; Biocompatible Materials; Calcinosis; Cattle; Delayed-Action Preparations; Diffusion; Glutaral; Heart Valve Prosthesis; Male; Phospholipids; Prostheses and Implants; Proteins; Rats; Rats, Sprague-Dawley; Silicone Elastomers; Sodium Dodecyl Sulfate; Swine

We compared the morphological findings in 15 young sheep in which standard Hancock-I cardiac bioprostheses (7 animals) and T6-processed Hancock-I (8 animals) were implanted in the tricuspid position. The animals were sacrificed at intervals from 8 to 47 weeks after valve replacement. No valvular infection was detected. Six of the 7 untreated valves and 5 of the 8 T6-processed valves in the tricuspid position showed calcific deposits in the radiographic examination. Roentgenograms from all specimens showed a fairly uneven distribution of the mineralization sites with the commissures being the structure most frequently involved. Calcium in the aortic wall was more frequent in the T6-processed group while right coronary leaflet involvement more frequent in the control group. Histologic evaluation confirmed the above data and showed a fibrotic reaction with granulomatous degeneration of the muscular shelf in all valves. Comparison of linear regression lines of the evolution of tissue calcium content with time showed no statistically significant difference between the 2 groups. Under the conditions of this study, the T6-treatment does not reduce the extent of calcification in the Hancock-I porcine xenograft after implantation in the tricuspid position in young sheep.

Topics: Animals; Bioprosthesis; Calcinosis; Heart Valve Prosthesis; Postoperative Complications; Sheep; Sodium Dodecyl Sulfate; Tricuspid Valve

Topics: Aortic Valve; Bioprosthesis; Calcinosis; Heart Valve Prosthesis; Humans; Sodium Dodecyl Sulfate

The effectiveness of a water-soluble C-12 alkyl sulfate (T6) (U.S. Patent No. 4,323,358) in retarding bioprosthetic calcification was evaluated in 23 porcine-valved conduits (13 T6-treated conduits and 10 controls) implanted in young sheep between the right ventricle and the pulmonary trunk. The grafts were divided into three groups according to the period of function: Group I, less than 2 months; Group II, 2 to 4 months; and Group III, 5 to 7 months. In Group I (four T6 and four controls), endocarditis occurred in five cases. In Group II (three T6 and three controls), four conduits showed severe fibrous peel ingrowth. In Group III (six T6 and three controls), fibrous peel was the main feature in four conduits and calcium deposits occurred in the porcine aortic wall in all cases, with cusp involvement in two; in both T6-treated and control conduits, chemical analysis showed a much lower calcium content of the cusps (8.45 +/- 80 versus 2.95 +/- 1.52 mg/gm dry weight, respectively) than that reported in other animal or human explants. The grade of calcification in control and T6-treated conduits was equal on x-ray analysis, and no differences in calcification patterns were noted on electron microscopy. This experimental model shows a low degree of cusp calcification and no significant differences between T6-treated and control conduits. Peel formation markedly interferes with performance of the porcine-valved conduit. The results of this analysis indicate that valved conduits are not the optimum model for evaluating calcium-retardant agents in biological valves.

Topics: Animals; Aortic Diseases; Bioprosthesis; Calcinosis; Endocarditis, Bacterial; Heart Valve Prosthesis; Sheep; Sodium Dodecyl Sulfate; Sulfuric Acid Esters; Sulfuric Acids; Surface-Active Agents; Swine; Time Factors